What top creators are saying about Foundayo(FOUNDAYO)

Eli Lilly oral GLP-1 medication discussed as a weight-management product.

1 AI-extracted insight from 1 source — podcasts, YouTube channels, and X/Twitter accounts.

Creator sentiment — last 30 days

Based on 1 scored insight about Foundayo.

Mixed
avg +0.00
0 bullish1 neutral0 bearish

Top creators covering Foundayo (FOUNDAYO)

The 1 sources with the most insights about Foundayo on Kazuha.

Latest insights about Foundayo (FOUNDAYO)

AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.

Yesterday

Neutral
Target: $149 self-pay price

Foundayo was discussed as a Lilly product available through the Hims partnership, which could make access more seamless.

Discussed alongside Foundayo (FOUNDAYO)

Other assets that creators frequently mention in the same content as Foundayo.

Frequently asked

Which podcasters and creators cover Foundayo (FOUNDAYO) the most?

The most active sources covering Foundayo (FOUNDAYO) on Kazuha are @BeatTheDenominator. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.

How many insights about Foundayo (FOUNDAYO) are on Kazuha?

Kazuha has indexed 1 AI-extracted insight about Foundayo (FOUNDAYO) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.

What other assets do creators discuss alongside Foundayo (FOUNDAYO)?

Creators covering Foundayo (FOUNDAYO) most frequently also discuss COST, AAPL, HIMS, TSLA, ZEPBOUND. See the "Discussed alongside" section above for full asset pages.